Investors Press Releases Nov 19 2024 Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association Read More Nov 01 2024 Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data Read More Oct 30 2024 Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million Read More btn News View All Events & Presentations Dec 14 2023 at 8:30 AM EST Dec 14 2023 at 8:30 AM EST Annual General Meeting 2023 Read More Jun 05 2023 at 12:30 PM EDT Jun 05 2023 at 12:30 PM EDT Tiziana Life Sciences: Foralumab Update in Non-Active Secondary Progressive Multiple Sclerosis (na SPMS) Read More Jan 09 2023 - Jan 11 2023 Jan 09 2023 - Jan 11 2023 Biotech Showcase Read More btn Events View All Interim Reports Interim Results for the Six Months Ended 30 June 2024 629.8 KB bth Interim Reports View All Annual Reports 20 F - Annual Report for the year ended 31 December 2023 8.9 MB btn ARs View All Annual General Meeting 2023 AGM Results 45.9 KB btn AGM View All Stock Quote Change Volume Today's Open Previous Close Today's High Today's Low 52 Week High 52 Week Low Stock Chart
Nov 19 2024 Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association Read More
Nov 01 2024 Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data Read More
Oct 30 2024 Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million Read More
Jun 05 2023 at 12:30 PM EDT Jun 05 2023 at 12:30 PM EDT Tiziana Life Sciences: Foralumab Update in Non-Active Secondary Progressive Multiple Sclerosis (na SPMS) Read More